These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 39102993)
1. Juglone suppresses vasculogenic mimicry in glioma through inhibition of HuR-mediated VEGF-A expression. Luo C; Chen G; Li R; Peng S; Zhang P; Wang F; Yu S; Zhu Y; Zhang J Biochem Pharmacol; 2024 Sep; 227():116458. PubMed ID: 39102993 [TBL] [Abstract][Full Text] [Related]
2. HNRNPA2B1 stabilizes NFATC3 levels to potentiate its combined actions with FOSL1 to mediate vasculogenic mimicry in GBM cells. Wang H; Shi Y; Zhou X; Zhang L; Yang A; Zhou D; Ma T Cell Biol Toxicol; 2024 Jun; 40(1):44. PubMed ID: 38862832 [TBL] [Abstract][Full Text] [Related]
3. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells. Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437 [TBL] [Abstract][Full Text] [Related]
4. Muscone derivative ZM-32 inhibits breast tumor angiogenesis by suppressing HuR-mediated VEGF and MMP9 expression. Yang LQ; Yu SP; Yang YT; Zhao YS; Wang FY; Chen Y; Li QH; Tian P; Zhu YY; Zhang JG; Lin GQ Biomed Pharmacother; 2021 Apr; 136():111265. PubMed ID: 33450490 [TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis. Gao Y; Yu H; Liu Y; Liu X; Zheng J; Ma J; Gong W; Chen J; Zhao L; Tian Y; Xue Y Cell Physiol Biochem; 2018; 45(1):131-147. PubMed ID: 29310118 [TBL] [Abstract][Full Text] [Related]
6. Dual role of exosomal circCMTM3 derived from GSCs in impeding degradation and promoting phosphorylation of STAT5A to facilitate vasculogenic mimicry formation in glioblastoma. Wang C; Liu Y; Zuo Z; Cui D; Xu Y; Li L; Jiang Y Theranostics; 2024; 14(14):5698-5724. PubMed ID: 39310105 [No Abstract] [Full Text] [Related]
7. Inhibition of Nodal suppresses angiogenesis and growth of human gliomas. Hueng DY; Lin GJ; Huang SH; Liu LW; Ju DT; Chen YW; Sytwu HK; Chang C; Huang SM; Yeh YS; Lee HM; Ma HI J Neurooncol; 2011 Aug; 104(1):21-31. PubMed ID: 21116837 [TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis. Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630 [TBL] [Abstract][Full Text] [Related]
9. ATM Activation is Key in Vasculogenic Mimicry Formation by Glioma Stem-like Cells. Xie J; Tang JX; Li Y; Kong X; Wang W; Wu H Biomed Environ Sci; 2024 Aug; 37(8):834-849. PubMed ID: 39198249 [TBL] [Abstract][Full Text] [Related]
10. Juglone reduces growth and migration of U251 glioblastoma cells and disrupts angiogenesis. Wang J; Liu K; Wang XF; Sun DJ Oncol Rep; 2017 Oct; 38(4):1959-1966. PubMed ID: 28791366 [TBL] [Abstract][Full Text] [Related]
11. An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells. Dong R; Chen P; Polireddy K; Wu X; Wang T; Ramesh R; Dixon DA; Xu L; Aubé J; Chen Q Mol Cancer Ther; 2020 Nov; 19(11):2267-2277. PubMed ID: 32879054 [TBL] [Abstract][Full Text] [Related]
12. Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1-mediated EMT. Zhang N; Zhang S; Wu W; Lu W; Jiang M; Zheng N; Huang J; Wang L; Liu H; Zheng M; Wang J Mol Carcinog; 2021 Feb; 60(2):151-163. PubMed ID: 33428809 [TBL] [Abstract][Full Text] [Related]
13. Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation. Rong X; Huang B; Qiu S; Li X; He L; Peng Y Oncotarget; 2016 Dec; 7(51):83976-83986. PubMed ID: 27824617 [TBL] [Abstract][Full Text] [Related]
14. The anti-angiogenic and anti-vasculogenic mimicry effects of GN25 in endothelial and glioma cells. Wen ZH; Chang L; Yang SN; Yu CL; Tung FY; Kuo HM; Lu IC; Wu CY; Shih PC; Chen WF; Chen NF Biochim Biophys Acta Mol Cell Res; 2024 Oct; 1871(7):119799. PubMed ID: 39043304 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of novel small molecule disruptors of HuR-mRNA interaction. Wu X; Lan L; Wilson DM; Marquez RT; Tsao WC; Gao P; Roy A; Turner BA; McDonald P; Tunge JA; Rogers SA; Dixon DA; Aubé J; Xu L ACS Chem Biol; 2015 Jun; 10(6):1476-84. PubMed ID: 25750985 [TBL] [Abstract][Full Text] [Related]
17. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer. Fan X; Huang J; Hu B; Zhou J; Chen L J Cancer Res Clin Oncol; 2023 Sep; 149(11):8729-8741. PubMed ID: 37129607 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of glioma growth by flavokawain B is mediated through endoplasmic reticulum stress induced autophagy. Wang J; Qi Q; Zhou W; Feng Z; Huang B; Chen A; Zhang D; Li W; Zhang Q; Jiang Z; Bjerkvig R; Prestegarden L; Thorsen F; Wang X; Li X; Wang J Autophagy; 2018; 14(11):2007-2022. PubMed ID: 30025493 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of CYR61 and CTGF by LM98: a synthetic YAP-TEAD inhibitor that targets in-vitro vasculogenic mimicry in glioblastoma cells. Roy ME; Veilleux C; Paquin A; Gagnon A; Annabi B Anticancer Drugs; 2024 Sep; 35(8):709-719. PubMed ID: 38900643 [TBL] [Abstract][Full Text] [Related]
20. Discovery of the anti-angiogenesis effect of eltrombopag in breast cancer through targeting of HuR protein. Zhu Y; Yang L; Xu J; Yang X; Luan P; Cui Q; Zhang P; Wang F; Li R; Ding X; Jiang L; Lin G; Zhang J Acta Pharm Sin B; 2020 Aug; 10(8):1414-1425. PubMed ID: 32963940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]